
Aethlon Medical, Inc. (AEMD) Stock Ticker
AEMD right now
Market factors today
Unlock the full AEMD picture
About Aethlon Medical, Inc.
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.
AEMD stock facts
| Ticker symbol | AEMD |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $3.3M |
| CEO | James Frakes |
| Employees | 9 |
| Headquarters | San Diego, CA, US |
| IPO date | 1999-03-04 |
| Website | www.aethlonmedical.com |
What you can see for AEMD on Tickr
Live AEMD price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the AEMD report.
Rankings
FAQ
What is the ticker symbol for Aethlon Medical, Inc.?
The ticker symbol for Aethlon Medical, Inc. is AEMD, listed on the NASDAQ Capital Market.
What is AEMD?
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental…